论文部分内容阅读
本文研究晚中期妊娠羊膜腔内注射地高辛终止妊娠,通过系统地观察孕妇地高辛吸收情况、心脏节律及血凝检查以确定其安全性。 1998年7～9月旧金山医院由超声确定妊娠18～23周要求终止妊娠者为研究对象,共8例选为系统性研究对象,年龄≥18岁,本人同意,并证明是活胎;凡有明显内科疾病或心血管疾病、最近应用心脏或抗高血压药物者、对地高辛过敏者、妊娠有并发症者(如:
In this paper, we study the termination of pregnancy by amniotic injection of digoxin in the second trimester of pregnancy, and systematically observe the absorption of digoxin, cardiac rhythm and blood coagulation in pregnant women to confirm their safety. From July to September 1998, San Francisco Hospital was identified by ultrasound as the target of termination of pregnancy from 18 to 23 weeks of gestation. A total of 8 patients were selected as the systematic study subjects. The age of consent was> 18 years old and proved to be alive Obvious medical disease or cardiovascular disease, the recent application of heart or antihypertensive drugs who are allergic to digoxin, pregnancy complications (such as: